By BERNIE BELLAN We’ve often heard that one of the main reasons Manitoba lags behind other provinces when it comes to economic development is because there is both a lack of entrepreneurial capital in this province and innovative individuals who are willing to base their operations here.
Thus, it was refreshing to hear of one young man who not only grew up in Winnipeg, but who has also decided to stay here and work to help turn a company which he co-founded into a successful start-up.
That young man’s name is Michael Lang, 37. I first met Michael when he was in a bar mitzvah class at Temple Shalom with my daughter, Shira. Having grown up in River Heights, the son of Ida and Sherman Lang, Michael attended, in order, Ecole Robert H. Smith, River Heights Middle School, and Kelvin High School.
Michael notes that, as a young boy, he and several other students, including Ben Carr, would go to Hebrew teacher Ethel Amihude’s home for Hebrew lessons. As a side note I should mention that the same day I interviewed Michael for this story, I also received a phone call from Ben Carr, who is now the Member of Parliament for Winnipeg South Centre. When I mentioned to Ben that I had just got off the phone with his former classmate Michael Lang, Ben said to me that, during the rally held in support of Israel on October 10, at which Ben spoke, he was approached by a woman who said, “I’ll bet you don’t remember me. I taught you Hebrew in my home.” Of course, it was Ethel Amihude – and yes, Ben did recognize her immediately.
Returning to Michael Lang – upon graduating from Kelvin High School, Michael enrolled at the University of Winnipeg to study science, with a particular interest in Physics, which is something he’s always loved, he says. Michael went on to complete his Masters and Ph.D. in Physics at the University of Manitoba, he notes, although his he did much of his research at the University of Winnipeg – “a great experience,” he observes.
I asked him how the Physics Department at the University of Winnipeg would compare with other Physics departments in Canada and the US and, although Michael acknowledges that “it’s a small faculty” – maybe 10 professors in total, they definitely “punch above their weight.”
Now, in order to keep this article at a level that would be understandable to most readers (and to this writer as well), I wanted to avoid asking Michael to go into any great detail about what his area of specialty in Physics was, but – just to give you a taste of what it was that he concentrated upon in his studies, here’s a brief excerpt from his bio on the company website (known as tauMEDIS) that he’s helped to found: “Michael received his Ph.D. in Physics from the University of Manitoba with work on hyperpolarized 129Xe gas production for high-precision co-magnetometry.”
The key word in that sentence is “magnetometry,” because it helps to explain how Michael’s research in that field eventually led him into the field of magnetic resonance imaging – or, as the acronym of that term is much more familiar to most of us: “MRI.”
By now, getting an MRI performed for a host of medical issues is something a lot of us expect to have done – and not with undue delays – and when we must wait for an MRI to be performed, which was something greatly exacerbated as a result of Covid disruptions to our medical system, it can be excruciatingly trying.
In the spring of 2020 – shortly after the start of the pandemic, Michael was working as a lab technician at the University of Winnipeg, where he maintained that university’s small animal MRI facility. It was then that the Principal Investigator of the lab, Dr. Melanie Martin, introduced Michael to members of a group working on a novel intraoperative MRI system. Michael would soon after join the group as a post-doctoral fellow, helping to lay the groundwork for what became tauMEDIS.
What is tauMEDIS? According to information available on its website, “Originally formed in 2018, and officially founded in 2023 by a group of Canadian scientists and engineers who are passionate about medical imaging, the name TauMEDIS is an acronym for tau Medical Imaging Solutions…” (tau is a letter in the Greek alphabet that “has significance in both magnetic resonance imaging as well as a variety of neurodegenerative diseases.”)
Although there are a host of other companies active in producing MRI systems, tauMEDIS has developed a particular type of technology in a specialized area of magnetic resonance imaging known as iMRI: “Intraoperative magnetic resonance imaging” or “iMRI,” for short. iMRI is a “method to acquire updated images of the brain throughout a neurosurgical procedure. Neurosurgeons rely on iMRI technology to obtain accurate images of the brain that guide them in removing brain tumors and treating other conditions such as epilepsy.”
Where tauMEDIS is unique in this highly specialized field though, is in its having developed a method to mobilize a full-sized MRI machine that, not only does not require the patient to be moved from the operating table into another room to have an MRI performed, it optimizes the installation process, allowing for retrofitting in existing operating rooms. (There is another company that makes moving magnet iMRI machines, known as IMRIS, that also allows the patient to remain on the operating table during surgery without having to be moved, but incorporating those particular systems into hospitals usually involves making major changes to the infrastructure of existing operating rooms.) The tauMEDIS system, Michael explains, minimizes renovations, and drastically reduces installation time in existing operating facilities.
“We developed a method to mobilize the MRI on a floor-moving track-based vehicle,” he says. “Essentially it’s a high-precision tank-like device that brings the MRI system to the patient undergoing neurosurgery,” providing the surgical team with updated images of the brain throughout the procedure.
tauMEDIS was just recently incorporated in Manitoba (six months ago). In March of this year its prototype machine received approval from the Food and Drug Administration in the US.
Now, in addition to his role as the company’s Chief Technology Officer, Michael, along with the other principals in the company, have found themselves in the position of having to seek out investment funds for tauMEDIS to commercialize the iMRI system they have developed. The funding would support development of a Winnipeg facility that would begin producing actual systems for sale.
“We just recently had our first showing at the Congress of Neurological Surgeons,” Michael says, “and now we’re in the fund-raising phase.”
I asked him how much money they’re seeking, and he says, “$200,000 to start.” I said to him that doesn’t seem like a lot to ask for and that I wondered whether having this article appear in this paper might not be just what it would take to elicit a positive response from some would-be investors.
Further, Michael notes that the goal of tauMEDIS “is to set up a local facility, combining manufacturing and R&D of tauMEDIS products, all located right here in Manitoba. We hope to attract and develop talent, growing the Winnipeg medical device sector.” (I should also mention that years ago, when I was writing about the Crocus Investment Fund, I noted that one of the first investee companies for Crocus was that very same IMRIS, to which I previously referred. I asked Michael if he knew whatever became of IMRIS back then since, according to Michael, it has now become very successful. As I recall, the Crocus Fund lost its entire investment in IMRIS. According to Michael, the company is now based in Minnesota. What happened after the Crocus debacle I’m not sure – just another example of a company that had a great idea but, for whatever reason, couldn’t succeed in Manitoba – although it did take off when it relocated elsewhere.)
Not only is tauMEDIS seeking capital to begin producing its iMRI systems, it also has other technological innovations in the works – all in the area of medical imaging. As Michael Lang says, his “goal as Chief Technology Officer is to work with physicians around the world to make advances in medical imaging technology and develop novel solutions” that would dramatically improve patient health outcomes.
If you would like to find out more about tauMEDIS, email info@taumedis.com or go to its website: taumedis.ca.